PE-Backed Drug Developer Case Study

Share on facebook
Share on linkedin
Share on twitter
Share on email
Share on print

A private equity-backed biopharmaceutical drug developer develops indication roadmap for phase 3 clinical trials and commercialization.

Read more: PE-Backed Drug Developer Case Study

Authors

Joe Giandomenico

Joe Giandomenico

Manager, Boston

Recent Posts

BCE Expands Senior Advisor Team

BCE has expanded its team of Senior Advisors. Amit Agarwal, Mark Kipphut, Doug Reep, David Ryan, Saurin Shah, and Jeff Tounge all strengthen BCE’s strategy and industry expertise and bolster our ability to serve corporate and private equity clients.

Follow Us